Gentex CFO reports stock grants and sales

Gentex Corp Chief Financial Officer Kevin C. Nash reported multiple stock transactions involving common shares.

Rhea-AI Filing Summary

Gentex Corp Chief Financial Officer Kevin C. Nash reported multiple stock transactions involving common shares. He acquired 13,880 shares on February 19, 2026 as a grant at no cost, increasing his holdings in that transaction to 73,310 shares.

On February 17, 2026, he received an additional grant of 38,181 performance-based shares, with the total number tied to long-term performance incentives and vesting 100% three years from the grant award date. The Form 4 also shows tax-withholding dispositions totaling 16,864 and 4,306 shares at $24.8900 per share, and open-market sales of 6,317 and 5,568 shares at $24.9767 per share.

After these transactions, Nash directly owned 59,430 common shares of Gentex Corp.

Insider Trade Summary

Net Seller: 11,885 shares

Net Sell 6 txns

Insider Nash Kevin C

Role Chief Financial Officer

Sold 11,885 shs ($297K)

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	13,880	$0.00	$0.00
Grant/Award	Common Stock	38,181	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	16,864	$24.89	$420K
Exercise Price or Tax Liability	Common Stock	4,306	$24.89	$107K
Sale	Common Stock	6,317	$24.9767	$158K
Sale	Common Stock	5,568	$24.9767	$139K

Holdings After Transaction: Common Stock — 73,310 shares (Direct)

Footnotes (2)

1. F1. 38,181 shares are performance-based shares where the total number of shares granted were based on long term performance incentives.
2. F2. These shares vest 100% three years from grant award date.

FAQ

What insider transactions did Gentex (GNTX) CFO Kevin Nash report?

Gentex CFO Kevin C. Nash reported stock grants, tax-related share dispositions, and open-market sales of common stock. The filing lists acquisition of award shares at no cost and subsequent sales and withholdings at prices around $24.89–$24.98 per share.

How many Gentex (GNTX) shares did the CFO sell in the latest Form 4?

Kevin C. Nash sold 6,317 and 5,568 Gentex common shares in open-market transactions. Both sales occurred on February 17, 2026 at an average price of about $24.9767 per share, according to the Form 4 insider trading report.

What performance-based Gentex (GNTX) shares were granted to the CFO?

The Gentex CFO received 38,181 performance-based common shares on February 17, 2026. A footnote explains the total number is tied to long-term performance incentives, and these shares are scheduled to vest 100% three years from the grant award date.

Did the Gentex (GNTX) CFO have tax-withholding share dispositions?

Yes. On February 17, 2026, Kevin C. Nash disposed of 16,864 and 4,306 Gentex common shares. The transactions were coded “F,” indicating payment of tax liability by delivering securities at a price of $24.8900 per share.

How many Gentex (GNTX) shares does the CFO own after these transactions?

After the reported grants, tax withholdings, and open-market sales, Kevin C. Nash directly owned 59,430 Gentex common shares. This total reflects his beneficial ownership immediately following the last transaction listed in the Form 4 filing.

Were the Gentex (GNTX) CFO’s new shares granted at a purchase price?

No. The Form 4 shows the newly acquired award shares had a per-share price of $0.0000. This indicates they were issued as grants or awards, not purchased in the open market for cash consideration.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/19/2026 - 04:38 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nash Kevin C

(Last) (First) (Middle)

600 NORTH CENTENNIAL STREET

(Street)

ZEELAND MI 49464

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GENTEX CORP [ GNTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/17/2026		A(1)		38,181	A	$0.00	92,485	D
Common Stock	02/17/2026		F		16,864	D	$24.89	75,621	D
Common Stock	02/17/2026		F		4,306	D	$24.89	71,315	D
Common Stock	02/17/2026		S		6,317	D	$24.9767	64,998	D
Common Stock	02/17/2026		S		5,568	D	$24.9767	59,430	D
Common Stock	02/19/2026		A(2)		13,880	A	$0.00	73,310	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. 38,181 shares are performance-based shares where the total number of shares granted were based on long term performance incentives.

2. These shares vest 100% three years from grant award date.

Remarks:

	/s/ Scott Ryan for Kevin C. Nash by Power of Attorney	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.